BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
Ovarian cancer typically presents at advanced stage with intra-abdominal metastases. Rarely, ovarian cancer presents with distant metastases with little to no intra-abdominal disease burden. The patient was a BRCA-2 germline mutation carrier diagnosed with a Stage IVB high-grade carcinoma of the fal...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578920301569 |
id |
doaj-a6489996b2344147ad2c56324ba323c1 |
---|---|
record_format |
Article |
spelling |
doaj-a6489996b2344147ad2c56324ba323c12021-02-11T04:21:45ZengElsevierGynecologic Oncology Reports2352-57892021-02-0135100690BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammographyJanelle N. Sobecki0Kathryn A. Dryer1Aparna M. Mahajan2Ryan J. Spencer3Division of Gynecologic Oncology, University of Wisconsin-Madison School of Medicine and Public Health, United States; Corresponding author at: 600 Highland Ave. H4/676, Madison, WI 53792, United States.Department of Obstetrics & Gynecology, University of Wisconsin-Madison School of Medicine and Public Health, United StatesDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, United StatesDivision of Gynecologic Oncology, University of Wisconsin-Madison School of Medicine and Public Health, United StatesOvarian cancer typically presents at advanced stage with intra-abdominal metastases. Rarely, ovarian cancer presents with distant metastases with little to no intra-abdominal disease burden. The patient was a BRCA-2 germline mutation carrier diagnosed with a Stage IVB high-grade carcinoma of the fallopian tube following discovery of a right axillary breast mass on screening mammography. Pre-operative imaging was without evidence of metastatic disease in the abdomen or pelvis. She underwent surgical staging followed by adjuvant chemotherapy and maintenance poly-ADP ribose polymerase (PARP) inhibition. She is without evidence of disease 24 months following her surgical staging procedure. An isolated oligo metastasis in the axilla is a rare presentation of ovarian carcinoma. Extra-abdominal metastases can present a diagnostic challenge in ovarian cancer necessitating thorough pathologic and radiologic work-up, particularly in the absence of intra-abdominal disease.http://www.sciencedirect.com/science/article/pii/S2352578920301569Ovarian cancer distant metastasisBRCA-2Breast massPARP inhibitor |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Janelle N. Sobecki Kathryn A. Dryer Aparna M. Mahajan Ryan J. Spencer |
spellingShingle |
Janelle N. Sobecki Kathryn A. Dryer Aparna M. Mahajan Ryan J. Spencer BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography Gynecologic Oncology Reports Ovarian cancer distant metastasis BRCA-2 Breast mass PARP inhibitor |
author_facet |
Janelle N. Sobecki Kathryn A. Dryer Aparna M. Mahajan Ryan J. Spencer |
author_sort |
Janelle N. Sobecki |
title |
BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography |
title_short |
BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography |
title_full |
BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography |
title_fullStr |
BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography |
title_full_unstemmed |
BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography |
title_sort |
brca-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography |
publisher |
Elsevier |
series |
Gynecologic Oncology Reports |
issn |
2352-5789 |
publishDate |
2021-02-01 |
description |
Ovarian cancer typically presents at advanced stage with intra-abdominal metastases. Rarely, ovarian cancer presents with distant metastases with little to no intra-abdominal disease burden. The patient was a BRCA-2 germline mutation carrier diagnosed with a Stage IVB high-grade carcinoma of the fallopian tube following discovery of a right axillary breast mass on screening mammography. Pre-operative imaging was without evidence of metastatic disease in the abdomen or pelvis. She underwent surgical staging followed by adjuvant chemotherapy and maintenance poly-ADP ribose polymerase (PARP) inhibition. She is without evidence of disease 24 months following her surgical staging procedure. An isolated oligo metastasis in the axilla is a rare presentation of ovarian carcinoma. Extra-abdominal metastases can present a diagnostic challenge in ovarian cancer necessitating thorough pathologic and radiologic work-up, particularly in the absence of intra-abdominal disease. |
topic |
Ovarian cancer distant metastasis BRCA-2 Breast mass PARP inhibitor |
url |
http://www.sciencedirect.com/science/article/pii/S2352578920301569 |
work_keys_str_mv |
AT janellensobecki brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography AT kathrynadryer brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography AT aparnammahajan brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography AT ryanjspencer brca2highgradeserousfallopiantubecancerdiagnosedasanisolatedbreastmassbymammography |
_version_ |
1724274627702685696 |